Nutritional Supplements Potassium Chloride Injection 1g 10ml 10′s/Box GMP

• Application: Internal Medicine
• Usage Mode: Injection
• Suitable for: Elderly, Children, Adult
• State: Liquid
• Shape: Oral Liquid
• Type: Biological Products
• Model NO.: AMC14055-02
• Pharmaceutical Technology: Chemical Synthesis
• Transport Package: 10′s/Box
• Specification: 1G/10ML
• Trademark: Shinepharm
• Origin: China
• HS Code: 3004909099
• Production Capacity: 1000000 Boxes/Month

Product Description

POTASSIUM CHLORIDE INJECTION 1G 10ML

Indications:

For use in patients requiring supplemental potassium therapy.

Dosage and Administration:

The goal of potassium replacement therapy is to elevate the plasma concentration of the ion to within the normal range.

Dose per day: Since the normal dietary intake of potassium is 50 to 100mmol daily, it is rare that a larger amount is required during potassium replacement therapy.

Precautions & Warning:

Administration

• Only use with specialist advice

• ECG should be used throughout and monitored continuously

• Initially do not use with glucose infusions - glucose may further decrease potassium levels

Other concurrent treatment

• Extreme caution in patients on potassium sparing diuretics and other drugs that may increase potassium

• Glucose infusion

Monitoring

• Continuous ECG monitoring - see above Administration

• Regular potassium levels especially in patients with renal impairment

Underlying conditions

• Dehydration must be corrected to ensure adequate urinary output (and potassium excretion)

• Where renal excretion of potassium or cellular uptake deficient - life threatening hyperkalaemia can occur with standard doses

• Extreme caution with extensive tissue destruction (eg burns)

• Extreme caution in cardiac disease

Contra-indications:

1.) Hypersensitivity to the active substance or to any of the excipients

2.) Sterile Potassium Chloride Injection should never be used undiluted.

3.) Hyperkalaemia (plasma-potassium concentration above 5 mmol/litre).

4.) Hyperchloraemia,

5.) Impaired renal function with oliguria, anuria or azotaemia

6.) Addison's disease,

7.) Acute dehydration

8.) Heat cramps.

Drug interactions:

Increased risk of severe hyperkalaemia with the following

• ACE-inhibitors

• Aliskerin

• Angiotensin-II receptor anatagonists

• Potassium sparing diuretics such as: amiloride, spironolactone and triamterene and aldosterone antagonists

• Ciclosporin

• Tacrolimus (not topical formulations)

Further reductions in potassium occurs with glucose infusions

Storage instructions:

Keep in outer carton. Do not store above 25°C.
Potassium Chloride Injection Other Specifications:

Product Code	Product Name	Specification
AMC14055-01	POTASSIUM CHLORIDE INJECTION	1G/10ML,10'S/BOX,5BOXES/MID BOX
AMC14055-03	POTASSIUM CHLORIDE INJECTION	1.5G/10ML,50'S/BOX
AMC14055-04	POTASSIUM CHLORIDE INJECTION	2G/10ML,5'S/BOX

Workshop

Quality Control

Warehousing

Certificates